Literature DB >> 22386586

Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture.

Andrew S Waxman1, Bruce G Kornreich, Russell A Gould, N Sydney Moïse, Jonathan T Butcher.   

Abstract

OBJECTIVES: The mechanisms of myxomatous valve degeneration (MVD) are poorly understood. Transforming growth factor-beta1 (TGFβ1) induces myofibroblastic activation in mitral valve interstitial cells (MVIC) in static 2D culture, but the roles of more physiological 3D matrix and cyclic mechanical strain are unclear. In this paper, we test the hypothesis that cyclic strain and TGFβ1 interact to modify MVIC phenotype in 3D culture. ANIMALS,
MATERIALS AND METHODS: MVIC were isolated from dogs with and without MVD and cultured for 7 days in type 1 collagen hydrogels with and without 5 ng/ml TGFβ1. MVIC with MVD were subjected to 15% cyclic equibiaxial strain with static cultures serving as controls. Myofibroblastic phenotype was assessed via 3D matrix compaction, cell morphology, and expression of myofibroblastic (TGFβ3, alpha-smooth muscle actin - αSMA) and fibroblastic (vimentin) markers.
RESULTS: Exogenous TGFβ1 increased matrix compaction by canine MVIC with and without MVD, which correlated with increased cell spreading and elongation. TGFβ1 increased αSMA and TGFβ3 gene expression, but not vimentin expression, in 15% cyclically stretched MVIC. Conversely, 15% cyclic strain significantly increased vimentin protein and gene expression, but not αSMA or TGFβ3. 15% cyclic strain however was unable to counteract the effects of TGFβ1 stimulation on MVIC.
CONCLUSIONS: These results suggest that TGFβ1 induces myofibroblastic differentiation (MVD phenotype) of canine MVIC in 3D culture, while 15% cyclic strain promotes a more fibroblastic phenotype. Mechanical and biochemical interactions likely regulate MVIC phenotype with dose dependence. 3D culture systems can systematically investigate these phenomena and identify their underlying molecular mechanisms. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22386586      PMCID: PMC3535465          DOI: 10.1016/j.jvc.2012.02.006

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  37 in total

1.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Tissue engineering science: consequences of cell traction force.

Authors:  R T Tranquillo; M A Durrani; A G Moon
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta.

Authors:  Q Li; Y Muragaki; I Hatamura; H Ueno; A Ooshima
Journal:  J Vasc Res       Date:  1998 Mar-Apr       Impact factor: 1.934

4.  Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.

Authors:  E Rabkin; M Aikawa; J R Stone; Y Fukumoto; P Libby; F J Schoen
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

5.  Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.

Authors:  Y Soini; J Satta; M Määttä; H Autio-Harmainen
Journal:  J Pathol       Date:  2001-06       Impact factor: 7.996

6.  Heart valve changes common to man and dog: a comparative study.

Authors:  A Pomerance; J C Whitney
Journal:  Cardiovasc Res       Date:  1970-01       Impact factor: 10.787

7.  Mechanical properties of myxomatous mitral valves.

Authors:  J E Barber; F K Kasper; N B Ratliff; D M Cosgrove; B P Griffin; I Vesely
Journal:  J Thorac Cardiovasc Surg       Date:  2001-11       Impact factor: 5.209

8.  Tissue and cell renewal in the natural aortic valve of rats: an autoradiographic study.

Authors:  P J Schneider; J D Deck
Journal:  Cardiovasc Res       Date:  1981-04       Impact factor: 10.787

9.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.

Authors:  Elena Rabkin-Aikawa; Mark Farber; Masanori Aikawa; Frederick J Schoen
Journal:  J Heart Valve Dis       Date:  2004-09

10.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells.

Authors:  Jonathan T Butcher; Robert M Nerem
Journal:  J Heart Valve Dis       Date:  2004-05
View more
  8 in total

1.  Prediction of matrix-to-cell stress transfer in heart valve tissues.

Authors:  Siyao Huang; Hsiao-Ying Shadow Huang
Journal:  J Biol Phys       Date:  2014-10-09       Impact factor: 1.365

Review 2.  Myocardial fibroblast-matrix interactions and potential therapeutic targets.

Authors:  Edie C Goldsmith; Amy D Bradshaw; Michael R Zile; Francis G Spinale
Journal:  J Mol Cell Cardiol       Date:  2014-01-26       Impact factor: 5.000

3.  Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.

Authors:  Kayle Shapero; Jill Wylie-Sears; Robert A Levine; John E Mayer; Joyce Bischoff
Journal:  J Mol Cell Cardiol       Date:  2015-01-26       Impact factor: 5.000

4.  Mechanical regulation of cardiac fibroblast profibrotic phenotypes.

Authors:  Kate M Herum; Jonas Choppe; Aditya Kumar; Adam J Engler; Andrew D McCulloch
Journal:  Mol Biol Cell       Date:  2017-05-03       Impact factor: 4.138

5.  Comparison of the mitral valve morphologies of Cavalier King Charles Spaniels and dogs of other breeds using 3D transthoracic echocardiography.

Authors:  Giulio Menciotti; Michele Borgarelli; Michael Aherne; Paula Camacho; Jens Häggström; Ingrid Ljungvall; Sunshine M Lahmers; Jonathan A Abbott
Journal:  J Vet Intern Med       Date:  2018-09-20       Impact factor: 3.333

6.  Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.

Authors:  Karen Tan; Greg Markby; Rhona Muirhead; Rachel Blake; Lisa Bergeron; Greg Fici; Kim Summers; Vicky Macrae; Brendan Corcoran
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

7.  Fibroblast mechanotransduction network predicts targets for mechano-adaptive infarct therapies.

Authors:  Jesse D Rogers; William J Richardson
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

Review 8.  Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human.

Authors:  Greg R Markby; Kim M Summers; Vicky E MacRae; Brendan M Corcoran
Journal:  Vet Sci       Date:  2017-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.